Inquis Medical, a developer of treatments for venous thromboembolic disease, announced the United States commercial launch of ...

September 29, 2026—iVascular announced new phase 2 data from the OPAL study of Amber, the company’s liquid embolic. The ...

The Society of Interventional Radiology (SIR) announced the publication of a study demonstrating that embolization greatly re ...

TriSalus Life Sciences, Inc. announced it has received FDA 510(k) clearance for the company’s TriNav Advance, which exp ...

The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) announced the start of patient enrollment in the ...

VS3 Medical, Inc., a developer of neurovascular implants, announced that the company’s VS3 system has been granted FDA ...

Route 92 Medical, Inc. announced FDA 510(k) clearance for the FreeClimb 46 catheter with Tenzing 4. The two components are en ...

Italy-based Dialybrid S.r.l. announced commencement of the first-in-human (FIH) trial of the company’s arteriovenous (A ...

Pulnovo Medical, a China-based developer of medical devices for pulmonary hypertension (PH) and heart failure (HF), announced ...

Mölnlycke Health Care US, LLC. announced the launch of the company’s range of Biogel radiation protection gloves, ...

Texray AB announced that interventional radiologist Ziv J. Haskal, MD, has joined the company’s clinical and scientific ...

Anaconda Biomed, a developer of a portfolio of thrombectomy catheters based on its core funnel catheter technology platform, ...